Good piece on NASH Play Conatus Pharmaceuticals. This stock cratered last week on trial results. Article explores why this might have been a huge overreaction by the market and a buying opportunity for intrepid investors. I personally would only do this within a buy-write option strategy using the $2.50 call strikes to mitigate risk myself...

Comments


Bret Jensen
EditorBret Jensen
Bret Jensen
EditorBret Jensen
Bret Jensen
EditorBret Jensen